Although the aforementioned studies focused on CD8+ T cells, it is expected that tumor infiltrates contain also virus-specific CD4+ CTL that could be exploited for therapy of solid cancers by applying similar therapeutic strategies. This evidence concerns the gene CD4 and neoplasm.